Nabriva Therapeutics plc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
Nabriva Therapeutics plc reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $1.42 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-24.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2017-03-24
- Nabriva Therapeutics plc fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2015 was $1.42M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|
| 2015-12-31 | $1.42M 10-K · filed 2017-03-24 |